Q3 revenues of EUR 24 (+19% vs. ARCe, -11% vs. cons)EBITDA of EUR 8.7m (+32% vs. ARCe, +2% vs. cons)82% contract coverage (incl. options) for 2026Equity narrative unchanged
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Q3 revenues of EUR 24 (+19% vs. ARCe, -11% vs. cons)EBITDA of EUR 8.7m (+32% vs. ARCe, +2% vs. cons)82% contract coverage (incl. options) for 2026Equity narrative unchanged
